The economic costs of precision medicine for clinical translational research among children with high-risk cancer
Christopher E L Owens(Macquarie University), Deborah Schofield(The University of Sydney), Vanessa Tyrrell(UNSW Sydney), Joice Kuroiwa‐Trzmielina(Children's Cancer Institute Australia), Owen Tan(The University of Sydney), Rupendra Shrestha(Macquarie University), Tracey O’Brien(Sydney Children's Hospital)
Cited by 12
Related Papers
A within-trial cost-effectiveness analysis of primary care referral to a commercial provider for weight loss treatment, relative to standard care—an international randomised controlled trial
|International Journal of Obesity|2012|2.1k
Diagnostic Impact and Cost-effectiveness of Whole-Exome Sequencing for Ambulant Children With Suspected Monogenic Conditions
|JAMA Pediatrics|2017|335
Prospective comparison of the cost-effectiveness of clinical whole-exome sequencing with that of usual care overwhelmingly supports early use and reimbursement
|Genetics in Medicine|2017|246
Whole-exome sequencing reanalysis at 12 months boosts diagnosis and is cost-effective when applied early in Mendelian disorders
|Genetics in Medicine|2018|200
Chronic disease and labour force participation among older Australians
|The Medical Journal of Australia|2008|189